| Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676) |
|---|
| 01/31/2008 | US20080027225 Isotopically marked quinoline derivatives as adenosin a3 receptor ligands |
| 01/31/2008 | US20080027101 Xinafoate salt of a substituted 5-oxazol-2-yl-quinoline compound |
| 01/31/2008 | US20080027100 Functionally selective alpha2C adrenoreceptor agonists |
| 01/31/2008 | US20080027098 Derivatives of alpha-phenylthiocarboxylic and alpha-phenyloxy-carboxylic acids useful for the treatment of diseases responding to PPARalpha activation |
| 01/31/2008 | US20080027097 Pharmaceutical drug candidates and methods for preparation thereof |
| 01/31/2008 | US20080027096 Novel Pharmaceutical Compositions |
| 01/31/2008 | US20080027060 Dipeptide nitriles |
| 01/31/2008 | US20080027059 Substituted isoxazolines, pharmaceutical compositions containing same, methods of preparing same, and uses of same |
| 01/31/2008 | US20080027054 4-Substituted quinolines as antitumor agents |
| 01/31/2008 | US20080027038 N-Acylated lipophilic amino acid derivatives |
| 01/31/2008 | US20080027001 Nogo receptor functional motifs, peptide mimetics, and mutated functional motifs related thereto, and methods of using the same |
| 01/31/2008 | CA2657247A1 Compounds which modulate the cb2 receptor |
| 01/30/2008 | EP1881830A1 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline derivatives the treatment of infertility |
| 01/30/2008 | CN101115802A Coloring matter for anisotropic coloring matter film, composition comprising said coloring matter, anisotropic coloring matter film, and polarizing element |
| 01/30/2008 | CN101115748A Acetamide compounds as fungicides |
| 01/29/2008 | US7323608 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 01/29/2008 | US7323596 Antibacterial or antiprotozoal activity: formula (1) formula (2) wherein: Z represents a radical of formula N(OH)CH( .dbd. O) or of formula C( .dbd. O)NH(OH); R1 represents hydrogen, methyl or trifluoromethyl, or, except when Z is a radical of |
| 01/29/2008 | US7323477 alpha2 adrenergic receptor agonist; inhibit secretion of epinephrine and norepinephrine; analgesic; chronic neuropathic and visceral pain; treatment of glaucoma or ocular hypertension; side effect reduction (as hypotension and sedation) |
| 01/29/2008 | US7323448 Antibacterial agents |
| 01/29/2008 | US7323447 Hepatitis C virus inhibitors |
| 01/29/2008 | CA2226058C 8-substituted-1,3,8-triaza-spiro[4.5]decan-4-one derivatives |
| 01/24/2008 | WO2008011476A2 Compositions and methods for modulating sirtuin activity |
| 01/24/2008 | WO2008009970A2 Process for the preparation of montelukast |
| 01/24/2008 | US20080021231 Novel compounds |
| 01/24/2008 | US20080021063 Compositions and methods for modulating sirtuin activity |
| 01/24/2008 | US20080021062 Alkylsulphonamide Quinolines |
| 01/24/2008 | US20080021029 Substituted Cyclic Urea Derivatives, Preparation Thereof And Pharmaceutical Use Thereof As Kinase Inhibitors |
| 01/24/2008 | US20080021027 Novel benzimidazole derivatives |
| 01/24/2008 | CA2658473A1 Process |
| 01/24/2008 | CA2658098A1 Selective androgen receptor modulators, analogs and derivatives thereof and uses thereof |
| 01/23/2008 | EP1881002A1 HCV NS-3 serine protease inhibitors |
| 01/23/2008 | EP1881001A1 HCV NS-3 serine protease inhibitors |
| 01/23/2008 | EP1880722A1 Pharmaceutical compositions of ciprofloxacin |
| 01/23/2008 | EP1879866A1 Dihydropyridine derivatives |
| 01/23/2008 | EP1879865A1 Syntheses and preparations of polymorphs of crystalline aripiprazole |
| 01/23/2008 | EP1879864A1 Fluorinated pyridine n-oxide thrombin modulators and process for n-oxidation of nitrogen containing heteroaryls |
| 01/23/2008 | EP1879581A1 4-PHENYL-5-0X0-l,4,5,6,7,8-HEXAHYDR0QËIN0LINE DERIVATIVES AS MEDICAMENTS FOR THE TREATMENT OF INFERTILITY |
| 01/23/2008 | EP1879580A1 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline derivatives as medicaments for the treatment of infertility |
| 01/23/2008 | EP1879564A2 Compounds to treat amyloidosis and prevent death of beta-cells in type 2 diabetes mellitus |
| 01/23/2008 | EP1747066B1 Collector for sulfidic ores |
| 01/23/2008 | EP1673086B1 4-aminoquinoline-3-carboxamide derivatives as pde4 inhibitors |
| 01/23/2008 | EP1667635A4 Sulfonylaminovalerolactams and derivatives thereof as factor xa inhibitors |
| 01/23/2008 | EP1501801B1 2,6-quinolinyl and 2,6-naphthyl derivatives and their use in the treatment of vla-4 dependent diseases |
| 01/23/2008 | EP1322651B1 Bicyclic heteroaromatic compounds |
| 01/23/2008 | CN101111488A Novel compounds |
| 01/23/2008 | CN101111481A Process of making crystalline aripiprazole |
| 01/23/2008 | CN101111249A Chemokine-binding heterocyclic compound salts, and methods of use thereof |
| 01/23/2008 | CN100363349C Process for preparing 5-'(r)-2-(5,6-diethyl-indian-2-ylamin o)-1-hydroxy-ethyl-8-hydroxy-(1h)-quinolin-2-one salt, useful as an adrenoceptor agonist |
| 01/23/2008 | CN100363348C PgD2 receptor antagonists for the treatment of inflammatory diseases |
| 01/22/2008 | US7321063 Sulfonamide inhibitors of aspartyl protease |
| 01/22/2008 | US7321036 Process for preparing aluminum trisquinoline complex |
| 01/22/2008 | US7321001 carboxylic acid derivatives which modulate the function and/or expression of proteins involved in atopic diseases, inflammatory conditions and cancer |
| 01/22/2008 | US7320989 E.g., {4-Chloro-3-[2-(3,4-dihydro-1H-isoquinolin-2-yl)ethoxy]phenyl}-(2-methylquinolin-4-yl)amine; congestive heart failure, stroke, antiischemic, -arrhythmia, -arthritis, -diabetic, -inflammatory, -ulcer and hypotensive agents; urogenital, bone, respiratory, cardiovascular and nervous systems disorders |
| 01/22/2008 | US7320983 Sulfur compounds such as phenylmethyl [2R-hydroxy-3-[(3-methylbutyl) (phenylsulfonyl)amino]-1S-(phenylmethyl)propyl]carbamate, used for prevention of viral diseases and replication |
| 01/22/2008 | CA2420999C 2-substituted heterocyclic compounds and their use in treating multidrug resistance |
| 01/22/2008 | CA2283101C Quinoline leukotriene antagonists |
| 01/17/2008 | WO2008007780A1 Pentadienamide derivative |
| 01/17/2008 | WO2008007211A1 Substituted n-bicyclicalkyl bicyclic carboxyamide compounds |
| 01/17/2008 | WO2008006836A1 Process for the preparation of chromene, thiochromene and dihydroquinoline derivatives from 2-hydroxy-, 2-mercapto- and 2-aminobenzaldehydes |
| 01/17/2008 | WO2008006627A1 Benzyl amines, a process for their production and their use as anti-inflammatory agents |
| 01/17/2008 | WO2008006287A1 Inreversible protein tyrosine kinases inhibitors and the preparation methods and uses thereof |
| 01/17/2008 | WO2007016476A3 Hepatitis c serine protease inhibitors and uses therefor |
| 01/17/2008 | WO2006137789A8 Quinoline 3 -sulfonate esters as NK3 receptor modulators |
| 01/17/2008 | US20080015360 2,3-Dimethyl-1-[(2,2,3,3-tetramethylcyclopropyl)carbonyl]-1H-imidazol-3-ium chloride; intermediate for preparing androstane-type glucocorticoid receptor agonists |
| 01/17/2008 | US20080015216 Histone Deacetylase Inhibitors |
| 01/17/2008 | US20080015193 Certain azoles exhibiting ATP-utilizing enzyme inhibitory activity, compositions, and uses thereof |
| 01/17/2008 | US20080015190 Inhibitors of Histone Deacetylase |
| 01/17/2008 | US20080015183 Substituted quinazolin-4-ylamine analogues |
| 01/17/2008 | US20080014173 N-(4,6-dimethyl-2-pyridinyl)-L-valyl- N-(1-((cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)-4-((6-methoxy-1-isoquinolinyl)carboxy)-L-prolinamide; viricide; synergistic with other active ingredients |
| 01/17/2008 | CA2659590A1 Irreversible protein tyrosine kinases inhibitors and the preparation methods and uses thereof |
| 01/17/2008 | CA2658097A1 Pentadienamide derivatives |
| 01/17/2008 | CA2657006A1 Benzyl amines, a process for their production and their use as anti-inflammatory agents |
| 01/16/2008 | EP1878722A1 Quinolinone derivatives and their pharmaceutical compositions |
| 01/16/2008 | EP1878717A1 Benzyl amines, a process for their production and their use as anti-inflammatory agents |
| 01/16/2008 | EP1877517A2 Luminous compound containing lanthanide ion |
| 01/16/2008 | EP1877383A1 Quinoline and quinoxaline derivatives as inhibitors of kinase enzymatic activity |
| 01/16/2008 | EP1877379A1 Hydroxybenzamide derivatives and their use as inhibitors of hsp90 |
| 01/16/2008 | EP1877364A1 Phenylacetylene derivatives having mglur5 receptor affinity |
| 01/16/2008 | EP1786823B1 Alkylidene tetrahydronaphthalene derivatives, method for their production and their use as anti-inflammatory agents |
| 01/16/2008 | EP1687288B1 Substituted aryl cycloalkanol derivatives and methods of their use |
| 01/16/2008 | EP1122242B1 Cyanophenyl derivatives |
| 01/16/2008 | CN101106991A 抗糖尿病的双环化合物 Bicyclic compounds antidiabetic |
| 01/16/2008 | CN101104598A Process for preparing trans-4-amino-1-cyclohexanecarboxilic acid derivatives |
| 01/15/2008 | US7319163 N-[3,5-Dibromo-4-(3-bromobenzyloxy)benzoyl]benzenesulphonamide for example; cardiac arrhythmias, thyrotoxicosis and subclinical hyperthyroidism |
| 01/15/2008 | US7319148 Comprising reactive hydrazide function used as initial synthons for preparing compounds capable of inducing mutations or capable of inhibiting a DNA polymerase or a kinase |
| 01/15/2008 | US7319100 1-(1H-Pyrazin-2-on-3-yl)tetrahydroquinolines (3-(8-Bromo-6-methoxy-1,2,3,4-tetrahydroquinoline)-5-chloro-1-(1-ethylpropyl)-2(1H)-pyrazinone); treating anxiety and depression |
| 01/15/2008 | US7319097 Treatment of type II diabetes with benzenesulfonamide substituted with an N-heterocycle: N-[2-amino-5-(1,4-diazepan-1-yl)phenyl]benzenesulfonamide, N-[4-amino-5-(piperazinyl)phenyl]benzenesulfonamide, 3-amino-4-(5-methyl-2,5-diaza-bicyclo[2.2.1]hept-2-yl)-N-phenyl-benzenesulfonamide hydrochloride |
| 01/15/2008 | US7318966 Luminescent element material and luminescent element comprising the same |
| 01/10/2008 | US20080009629 Novel Form of a Benzenesulfonamide Derivative |
| 01/10/2008 | US20080009518 5-Phenyl-5,6,7,8-Hydroquinoline Tachykinin Receptor Antagonists |
| 01/10/2008 | US20080009512 Tetrahydroquinolones and Aza-Analogues Thereof for Use as Dpp-IV Inhibitors in the Treatment of Diabetes |
| 01/10/2008 | US20080009506 Imidazole Compound |
| 01/10/2008 | US20080009498 Phosphodiesterase inhibitors and nitric oxide donors, compositions and methods of use |
| 01/10/2008 | US20080009495 Compound Containing Basic Group and Use Thereof |
| 01/10/2008 | US20080009470 Acremonic Acid Derivatives |
| 01/10/2008 | CA2657702A1 Quinazolines and related heterocyclic comp0unds, and their therapeutic use |
| 01/09/2008 | EP1876174A1 Quinoline and quinazoline derivatives having affinity for 5HT1-type receptors |
| 01/09/2008 | EP1874759A1 C-met modulators and methods of use |
| 01/09/2008 | EP1874731A2 Quinobenzoxazine analogs and methods of using thereof |
| 01/09/2008 | EP1874721A2 Glycine transport inhibitors |